Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications

被引:0
|
作者
Ke-Yu Zeng [1 ]
Wu-Yong-Ga Bao [1 ]
Yun-Han Wang [1 ]
Min Liao [1 ]
Jie Yang [1 ]
Jia-Yan Huang [1 ]
Qiang Lu [1 ]
机构
[1] Department of Medical Ultrasound,West China Hospital of Sichuan University
关键词
D O I
暂无
中图分类号
R575 [肝及胆疾病];
学科分类号
1002 ; 100201 ;
摘要
In the world, nonalcoholic fatty liver disease(NAFLD) accounts for majority of diffuse hepatic diseases. Notably, substantial liver fat accumulation can trigger and accelerate hepatic fibrosis, thus contributing to disease progression. Moreover, the presence of NAFLD not only puts adverse influences for liver but is also associated with an increased risk of type 2 diabetes and cardiovascular diseases. Therefore, early detection and quantified measurement of hepatic fat content are of great importance. Liver biopsy is currently the most accurate method for the evaluation of hepatic steatosis. However, liver biopsy has several limitations, namely, its invasiveness, sampling error, high cost and moderate intraobserver and interobserver reproducibility. Recently, various quantitative imaging techniques have been developed for the diagnosis and quantified measurement of hepatic fat content, including ultrasound-or magnetic resonancebased methods. These quantitative imaging techniques can provide objective continuous metrics associated with liver fat content and be recorded for comparison when patients receive check-ups to evaluate changes in liver fat content, which is useful for longitudinal follow-up. In this review, we introduce several imaging techniques and describe their diagnostic performance for the diagnosis and quantified measurement of hepatic fat content.
引用
收藏
页码:2534 / 2550
页数:17
相关论文
共 50 条
  • [41] Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway
    Andy McKay
    Carlos Pantoja
    Richard Hall
    Sarah Matthews
    Phil Spalding
    Rajarshi Banerjee
    Journal of Patient-Reported Outcomes, 5
  • [42] Non-invasive diagnosis of steatosis and fibrosis
    Castera, L.
    DIABETES & METABOLISM, 2008, 34 (06) : 674 - 679
  • [43] Non-invasive diagnosis of hepatic steatosis
    Stern, Christiane
    Castera, Laurent
    HEPATOLOGY INTERNATIONAL, 2017, 11 (01) : 70 - 78
  • [44] Imaging of primary sclerosing cholangitis (PSC) by two new non-invasive techniques
    Macchi, V
    Floreani, A
    Marchesi, P
    Pasini, R
    Zuliani, M
    Baragiotta, A
    Bologna, L
    Feltrin, G
    Miotto, D
    JOURNAL OF HEPATOLOGY, 2003, 38 : 186 - 186
  • [45] Preventing myocardial infarction: use and limitation of non-invasive imaging modalities
    Perna, Gian Piero
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0E) : E110 - E112
  • [46] Non-invasive imaging modalities to study neurodegenerative diseases of aging brain
    Annavarapu, Ramesh Naidu
    Kathi, Srujana
    Vadla, Vamsi Krishna
    JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 95 : 54 - 69
  • [47] Current and novel non-invasive imaging modalities in vascular neurosurgical practice
    Bautista, Melissa
    Saleem, Nayyar
    Anderson, Ian A.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2020, 81 (12)
  • [48] Non-Invasive Imaging Modalities in Intravesical Murine Models of Bladder Cancer
    Relouw, Sydney
    Dugbartey, George J. J.
    Sener, Alp
    CANCERS, 2023, 15 (08)
  • [49] Non-invasive imaging techniques to assess myocardial perfusion
    Villemain, Olivier
    Baranger, Jerome
    Jalal, Zakaria
    Lam, Christopher
    Calais, Jeremie
    Pernot, Mathieu
    Cifra, Barbara
    Friedberg, Mark K.
    Mertens, Luc
    EXPERT REVIEW OF MEDICAL DEVICES, 2020, 17 (11) : 1133 - 1144
  • [50] Evaluation of liver fibrosis by non-invasive methods
    Tor, Jordi
    Muga, Roberto
    MEDICINA CLINICA, 2011, 137 (14): : 642 - 644